Steep Decline in Chlamydia, Syphilis Rates 'Seals the Case' for DoxyPEP

(MedPage Today) -- DENVER -- Chlamydia and early syphilis cases among at-risk individuals were halved after the introduction of doxycycline post-exposure prophylaxis (doxyPEP), real-world data from San Francisco showed. Over a 13-month period...
Source: MedPage Today Infectious Disease - Category: Infectious Diseases Source Type: news